InvestorsHub Logo
Followers 0
Posts 7389
Boards Moderated 0
Alias Born 08/03/2012

Re: HNDRXX post# 9212

Monday, 07/06/2020 11:29:32 PM

Monday, July 06, 2020 11:29:32 PM

Post# of 90082
While Patrick Netter has made a name for himself in marketing products, people should be questioning why he is selling virexit.com in the first place if he could be successful with it. Navigating to the website the answer is clear, there is nothing proprietary or that jumps out as innovative, so the question should be what "intellectual property" are they actually buying. Here is the product offering and why success will be limited at best;

- Disinfectants : this must be a joke. You could easily buy lysol or hospital grade disinfectants that have already gone through years of R&D. This market is already saturated.

PPE : all the website says is, "masks, gloves, hoods, shields, covers". Again, nothing innovative as these are commodities and not specialty products. You can easily buy latex/nitrile hospital grade gloves, tyvex body suites and similar for the other products.

Antiviral Medication : This is also a joke. Virexit.com does not own any medication. If the play here is finding a COVID-19 company to acquire, best of luck competing with real blue chip companies ahead of the curve.

All in all, virexit.com doesn't seem to have much of anything, just words and nothing you can buy off the website. The new CEO who has been slapped by FINRA before is likely using the opportunity to buy a company worth <$250K to build a story and sell shares with intention of just enriching himself as he has supposedly done on previous plays.

To those drinking the kool-aid, play it smart and sell into the pump. The wolves are in the house.